Analysts Issue Forecasts for NTLA FY2026 Earnings
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Intellia Therapeutics in a report released on Monday, June 9th. Cantor Fitzgerald analyst R. Bienkowski expects that the company will post earnings of ($3.05) per share for the year. The consensus estimate for Intellia Therapeutics’ […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Intellia Therapeutics in a report released on Monday, June 9th. Cantor Fitzgerald analyst R. Bienkowski expects that the company will post earnings of ($3.05) per share for the year. The consensus estimate for Intellia Therapeutics’ […]
